Occupational Diseases Department, CHU de Rennes, Université de Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, 35000 Rennes, France.
CHU de Rennes, 35000 Rennes, France.
Infect Dis Now. 2022 Jun;52(4):223-226. doi: 10.1016/j.idnow.2022.04.007. Epub 2022 May 2.
To characterize the willingness to get the third COVID-19 vaccine dose among health care workers (HCWs).
A cross-sectional study using a self-administered questionnaire proposed on a voluntary basis to all HCWs of a French teaching hospital in October and November 2021.
Of 1,655 HCWs who completed the questionnaire, 64.2% were willing to receive the third dose, 20.1% were hesitant, and 15.7% were reluctant. On multivariate analysis, older age (P<0.0001), medical and executive staff, willingness to receive the flu vaccine (OR=5.72 [4.24-7.64]), previous vaccine scheme with ChAdOx1 nCoV-19 (AstraZeneca) (OR=2.13 [1.58-2.87]), and history of COVID-19 with a complete COVID-19 vaccine scheme (OR=2.77 [1.04-7.41]) were independent predictors of HCWs' willingness to get the third dose.
One third of HCWs were hesitant or opposed to a third COVID-19 vaccine dose. Better knowledge of determinants of the willingness to get this third dose may improve communication and vaccine strategy.
描述医护人员（HCWs）接种第三剂 COVID-19 疫苗的意愿。
这是一项横断面研究，于 2021 年 10 月至 11 月期间，采用自愿原则向法国一所教学医院的所有 HCWs 发放自行设计的调查问卷。
在完成问卷的 1655 名 HCWs 中，64.2%表示愿意接种第三剂，20.1%犹豫不决，15.7%表示不愿意。多因素分析显示，年龄较大（P<0.0001）、医疗和行政人员、愿意接种流感疫苗（OR=5.72 [4.24-7.64]）、先前采用 ChAdOx1 nCoV-19（阿斯利康）疫苗方案（OR=2.13 [1.58-2.87]）以及完成 COVID-19 疫苗接种方案的 COVID-19 病史（OR=2.77 [1.04-7.41]）是 HCWs 接种第三剂意愿的独立预测因素。
三分之一的 HCWs 对第三剂 COVID-19 疫苗犹豫不决或反对。更好地了解接种第三剂疫苗意愿的决定因素，可能有助于改善沟通和疫苗策略。
